WeVote
Log In

Bill

Bill

HD 1913

An Act to address barriers to HIV prevention medication

194th Legislature (2025-2026) Introduced by Jack Lewis

Massachusetts bill allowing pharmacists to dispense HIV prevention drugs (PrEP/PEP) without prior authorization to expand access and reduce transmission risk.

0
WeVote Research Nonpartisan
Bill Summary · HD 1913

Legislative bill overview

HD 1913 proposes removing barriers to accessing HIV prevention medications (PrEP and PEP) in Massachusetts by streamlining prescription and insurance coverage requirements. The bill aims to make these preventive medications more accessible, particularly through pharmacist-initiated dispensing and reduced prior authorization hurdles.

Why is this important

HIV prevention medications are highly effective at reducing transmission risk but remain underutilized due to access barriers. Removing procedural obstacles could expand preventive treatment to vulnerable populations and reduce new HIV infections, with potential public health and healthcare cost benefits.

Potential points of contention

  • Insurance coverage costs: Expanding coverage may increase insurer expenses, potentially affecting premium rates or requiring pharmaceutical rebate negotiations
  • Pharmacist scope of practice: Allowing pharmacists to initiate prescriptions without physician involvement raises questions about oversight, liability, and appropriate clinical judgment in individual cases
  • Equitable access concerns: Removing barriers doesn't guarantee equitable outcomes if underlying disparities in pharmacy access or health literacy persist in underserved communities
  • Preventive vs. treatment priorities: Budget constraints may create tradeoffs between prevention funding and treatment resources for those already infected

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.